We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Bradley McGregor

Bradley McGregor MD

Clinical Director, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA

Dr. Bradley A. McGregor, a medical oncologist specializing in genitourinary malignancies, is Clinical Director of the Dana-Farber Cancer Institute Lank Center for Genitourinary Oncology in Boston. After receiving his medical degree from Tufts University School of Medicine, Dr. McGregor joined the United States Air Force at the San Antonio Uniformed Services Health Education Consortium. He completed residency training in internal medicine and fellowship training in hematology/oncology while in the military. Presently, he is actively involved in clinical research in the area of genitourinary malignancies, and is serving as primary investigator for several ongoing trials.


Dr. McGregor reports the following disclosures: 

Consultant for Bayer, Astellas, Astra Zeneca, Seattle Genetics, Exelixis, Nektar, Pfizer, Janssen, Genentech; Research support to institution from Bristol Myers Squibb;